Similar articles for PMID: 29147974

Year	Number of Results
1997	2
1998	2
2000	4
2001	2
2002	3
2004	3
2005	2
2006	4
2007	2
2008	4
2009	6
2010	5
2011	7
2012	10
2013	10
2014	13
2015	5
2016	4
2017	8
2018	8
2019	4
2020	12
2021	12
2022	5
2024	0

1

Baharlou R, Romani B, Kiani SJ, Sadeghi K, Shadmand E, Fazel H, Jalilian FA, Kord E, Yaghoubi S, Nikmanesh Y, Ahmadi Vasmehjani A. Baharlou R, et al. Med Microbiol Immunol. 2018 Feb;207(1):65-74. doi: 10.1007/s00430-017-0527-9. Epub 2017 Nov 17. Med Microbiol Immunol. 2018. PMID: 29147974

2

Serum levels of Th17 associated cytokines in chronic hepatitis C virus infection.

Sousa GM, Oliveira IS, Andrade LJ, Sousa-Atta ML, Paraná R, Atta AM. Sousa GM, et al. Cytokine. 2012 Oct;60(1):138-42. doi: 10.1016/j.cyto.2012.06.003. Epub 2012 Jun 27. Cytokine. 2012. PMID: 22748467 Free article.

3

Combined impact of hepatitis C virus genotype 1 and interleukin-6 and tumor necrosis factor-α polymorphisms on serum levels of pro-inflammatory cytokines in Brazilian HCV-infected patients.

Tarragô AM, da Costa AG, Pimentel JP, Gomes ST, Freitas FB, Lalwani P, de Araújo AR, Victória Fda S, Victória MB, Vallinoto AC, Sadahiro A, Teixeira-Carvalho A, Martins-Filho OA, Malheiro A. Tarragô AM, et al. Hum Immunol. 2014 Nov;75(11):1075-83. doi: 10.1016/j.humimm.2014.08.198. Epub 2014 Sep 3. Hum Immunol. 2014. PMID: 25193024

4

Imbalance of regulatory T cells and T helper type 17 cells in patients with chronic hepatitis C.

Hao C, Zhou Y, He Y, Fan C, Sun L, Wei X, Wang L, Peng M, Wang P, Lian J, Jia Z. Hao C, et al. Immunology. 2014 Dec;143(4):531-8. doi: 10.1111/imm.12330. Immunology. 2014. PMID: 24903732 Free PMC article.

5

Role of Th1/Th2 cytokines in serum on the pathogenesis of chronic hepatitis C and the outcome of interferon therapy.

Zhang L, Hao CQ, Miao L, Dou XG. Zhang L, et al. Genet Mol Res. 2014 Nov 27;13(4):9747-55. doi: 10.4238/2014.November.27.2. Genet Mol Res. 2014. PMID: 25501184 Free article.

6

Involvement of the Interleukin-23/Interleukin-17 Axis in Chronic Hepatitis C Virus Infection and Its Treatment Responses.

Meng P, Zhao S, Niu X, Fu N, Su S, Wang R, Zhang Y, Qiao L, Nan Y. Meng P, et al. Int J Mol Sci. 2016 Jul 15;17(7):1070. doi: 10.3390/ijms17071070. Int J Mol Sci. 2016. PMID: 27428948 Free PMC article.

7

Immunomodulators, sFas and Fas-L as potential noninvasive predictors of IFN treatment in patients with HCV genotype-4.

Zekri AR, Haleem HA, Esmat GE, Bahnassy AA, El-Din HM, Hafez MM, Sharaby AF, Sharaf H, Zakaria MS. Zekri AR, et al. J Viral Hepat. 2007 Jul;14(7):468-77. doi: 10.1111/j.1365-2893.2006.00832.x. J Viral Hepat. 2007. PMID: 17576388 Clinical Trial.

8

Impact of HIV infection in patients infected with chronic HCV (genotypes 1a and 3a): virological and clinical changes.

Behzadpour D, Ahmadi Vasmehjani A, Mousavi Nasab SD, Ahmadi NA, Baharlou R. Behzadpour D, et al. Pathog Glob Health. 2016 Oct-Dec;110(7-8):310-315. doi: 10.1080/20477724.2016.1253532. Epub 2016 Nov 10. Pathog Glob Health. 2016. PMID: 27830997 Free PMC article.

9

mRNA cytokine profile in peripheral blood cells from chronic hepatitis C virus (HCV)-infected patients: effects of interferon-alpha (IFN-alpha) treatment.

Shapiro S, Gershtein V, Elias N, Zuckerman E, Salman N, Lahat N. Shapiro S, et al. Clin Exp Immunol. 1998 Oct;114(1):55-60. doi: 10.1046/j.1365-2249.1998.00693.x. Clin Exp Immunol. 1998. PMID: 9764603 Free PMC article.

10

Impact of Schistosoma mansoni co-infection on serum profile of interferon-gamma, interleukin-4 and interleukin-10 in patients with chronic hepatitis C virus infection.

Emam EA, Emam M, Shehata AE, Emara M. Emam EA, et al. Egypt J Immunol. 2006;13(2):33-40. Egypt J Immunol. 2006. PMID: 18689269

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

122 results

Results by year